Antiarrhythmic drug therapy in the management of atrial fibrillation

被引：21

作者：

Ganz, LI

Antman, EM

机构：

[1] BRIGHAM & WOMENS HOSP, DIV CARDIOVASC, BOSTON, MA 02115 USA

[2] HARVARD UNIV, SCH MED, BOSTON, MA USA

来源：

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY | 1997年 / 8卷 / 10期

关键词：

atrial fibrillation; atrial flutter; review; antiarrhythmic therapy; antiarrhythmic agents;

D O I：

10.1111/j.1540-8167.1997.tb01005.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Antiarrhythmic Drugs for AF. Antiarrhythmic drugs have been used for the acute conversion of atrial fibrillation to sinus rhythm, as well as for the long-term maintenance of sinus rhythm. In recent years, concerns regarding antiarrhythmic drug efficacy as well as safety have prompted a re-examination of the indications for antiarrhythmic therapy in patients with atrial fibrillation. This review will focus on the safety and efficacy of antiarrhythmic therapy in the acute and chronic management of patients with atrial fibrillation.

引用

收藏

页码：1175 / 1189

页数：15

相关论文

共 99 条

[1] OCCURRENCE OF VENTRICULAR ARRHYTHMIAS IN PATIENTS RECEIVING ACUTE AND CHRONIC INFUSIONS OF MILRINONE [J].

ANDERSON, JL ;

ASKINS, JC ;

GILBERT, EM ;

MENLOVE, RL ;

LUTZ, JR .

AMERICAN HEART JOURNAL, 1986, 111 (03) :466-474

[2] PREVENTION OF SYMPTOMATIC RECURRENCES OF PAROXYSMAL ATRIAL-FIBRILLATION IN PATIENTS INITIALLY TOLERATING ANTIARRHYTHMIC THERAPY - A MULTICENTER, DOUBLE-BLIND, CROSSOVER STUDY OF FLECAINIDE AND PLACEBO WITH TRANSTELEPHONIC MONITORING [J].

ANDERSON, JL ;

GILBERT, EM ;

ALPERT, BL ;

HENTHORN, RW ;

WALDO, AL ;

BHANDARI, AK ;

HAWKINSON, RW ;

PRITCHETT, ELC .

CIRCULATION, 1989, 80 (06) :1557-1570

[3]

[Anonymous], 1989, NEW ENGL J MED, V321, P406

[4] ATRIAL-FIBRILLATION AND FLUTTER - MAINTAINING STABILITY OF SINUS RHYTHM VERSUS VENTRICULAR RATE CONTROL [J].

ANTMAN, EM .

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1995, 6 (10) :962-971

[5] THERAPY OF REFRACTORY SYMPTOMATIC ATRIAL-FIBRILLATION AND ATRIAL-FLUTTER - A STAGED CARE APPROACH WITH NEW ANTIARRHYTHMIC DRUGS [J].

ANTMAN, EM ;

BEAMER, AD ;

CANTILLON, C ;

MCGOWAN, N ;

FRIEDMAN, PL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (03) :698-707

[6] LONG-TERM ORAL PROPAFENONE THERAPY FOR SUPPRESSION OF REFRACTORY SYMPTOMATIC ATRIAL-FIBRILLATION AND ATRIAL-FLUTTER [J].

ANTMAN, EM ;

BEAMER, AD ;

CANTILLON, C ;

MCGOWAN, N ;

GOLDMAN, L ;

FRIEDMAN, PL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 12 (04) :1005-1011

[7] LONG-TERM THERAPY WITH DISOPYRAMIDE PHOSPHATE - SIDE-EFFECTS AND EFFECTIVENESS [J].

BAUMAN, JL ;

GALLASTEGUI, J ;

STRASBERG, B ;

SWIRYN, S ;

HOFF, J ;

WELCH, WJ ;

BAUERNFEIND, RA .

AMERICAN HEART JOURNAL, 1986, 111 (04) :654-660

[8] EFFECTIVENESS OF INTRAVENOUS PROPAFENONE FOR CONVERSION OF RECENT-ONSET ATRIAL-FIBRILLATION - A PLACEBO-CONTROLLED STUDY [J].

BELLANDI, F ;

CANTINI, F ;

PEDONE, T ;

PALCHETTI, R ;

BAMOSHMOOSH, M ;

DABIZZI, RP .

CLINICAL CARDIOLOGY, 1995, 18 (11) :631-634

[9]

*BERL LAB, 1994, BET PACK INS

[10]

Boissel J P, 1981, Eur Heart J, V2, P49

← 1 2 3 4 5 6 7 8 9 10 →